This product is not clubbable with other items in cart. Please remove this or other items to proceed further.
Products from multiple soldto's are in cart. Only products from single soldto is allowed in cart.
No Items In Cart
Celebrating its 30th anniversary, Canine Partners for Life (CPL) has been dedicated to training service dogs, home companion dogs, residential companion dogs, and courthouse companion dogs to assist individuals who have a wide range of physical, neurological, and cognitive disabilities.
The mission of CPL is to increase the independence and quality of life of individuals with physical, developmental, and cognitive disabilities or who are in other situations of need. Since its inception, CPL has placed more than 700 service and companion dogs in 45 states.
CPL’s service dogs go through an intense two-year training program. In addition to learning advanced obedience and social skills, they learn techniques to help people with disabilities meet the challenges of daily living. CPL’s programs include:
Since it was chosen as one of our local charities of choice in 2010, West has had a special relationship with CPL. For the past nine years, West has continued to support and be involved with CPI, including through its team members who have raised and fostered service dogs. Two of our very own team members, Janet Cooper, Manager, Administrative Services and Erin O’Brien, VP Product Management and Marketing Operations feel very passionate about CPL’s mission and take every opportunity to spread the word about the impact service and home companion dogs have on people’s lives by serving on CPL’s Board of Directors.
“Seeing the difference in the recipient’s lives is my favorite part of being a volunteer for CPL. Once you see the impact they make, and you hear the stories, it makes you want to keep helping,” said West team member and CPL Board Member, Janet Cooper.
To learn more about Canine Partners for Life or how you can get involved, visit their website here.
Take an in-depth look at the science behind containment & delivery of injectable medicines in the West Knowledge Center.
Glucose monitoring, or measuring the amount of sugar in the blood, is a vital part of everyday care for those suffering from diabetes. Traditional tests require patients to prick their fingers and place a drop of blood on a test strip. The strip is then placed in a glucose meter that reports the results to the patient. While this test is very accurate, it offers a reading for only a single point in time. For patients to get a range of their blood glucose levels, more frequent data is needed at a variety of different times.
<p><em>Lloyd Waxman, Harold Murray and Vinod Vilivalam</em></p><div id="g_93cd4f5a_be87_417c_be5f_5391eae75b241"><div><div><em></em> </div><div><strong>ABSTRACT</strong></div><div><strong> </strong></div><div><strong>Purpose: </strong>The shipment and storage of biopharmaceuticals in prefilled syringes (PFS) places new demands on PFS performance. Studies compared package integrity of glass and plastic PFS: piston movement was evaluated under reduced pressures to simulate transport by air in non-pressurized holds, and container closure integrity was tested on PFS that had been frozen or frozen and thawed, since some biopharmaceuticals are stored and transported in the frozen state. Piston release and travel forces were also measured in plastic PFS since in order to be competitive with siliconized glass PFS, the functional characteristics of plastic PFS must meet or exceed the criteria established for glass PFS.</div></div></div>
With the help of the FDA’s expedited programs for approval, a new wave of high-value biologic drugs is on the rise in the pharma industry.1 These drugs require cryogenic storage (-80oC to -180oC) to maintain stability. This presents a new challenge: how to measure and demonstrate container closure integrity (CCI) of storage and delivery systems at such low temperatures.<br />
To continue to learn and innovate is truly a daunting task. The journey to success has many ups and downs, but the end of that journey is not necessarily about knowing what worked or did not, but what to do with those learnings. In West’s journey to becoming a world leader in integrated containment and delivery (i.e., our learning experience), we continue to focus on market needs and listen to the voice of the customer.
In 2015, the FDA shed light on a problematic practice within the healthcare industry involving improper, off-label use of syringes as closed container storage systems for compounded or repackaged drugs. The incidents cited revealed that interaction with rubber plungers in syringes that were not cleared for the purpose of closed container storage resulted in the loss of potency of several drugs when administration was delayed.<sup>1</sup>